166 related articles for article (PubMed ID: 14684272)
1. Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco-2 cells.
Paukner S; Kohl G; Lubitz W
J Control Release; 2004 Jan; 94(1):63-74. PubMed ID: 14684272
[TBL] [Abstract][Full Text] [Related]
2. Bacterial ghosts (BGs)--advanced antigen and drug delivery system.
Kudela P; Koller VJ; Lubitz W
Vaccine; 2010 Aug; 28(36):5760-7. PubMed ID: 20619379
[TBL] [Abstract][Full Text] [Related]
3. Sealed bacterial ghosts--novel targeting vehicles for advanced drug delivery of water-soluble substances.
Paukner S; Kohl G; Jalava K; Lubitz W
J Drug Target; 2003 Apr; 11(3):151-61. PubMed ID: 13129825
[TBL] [Abstract][Full Text] [Related]
4. Enhanced anti-proliferative efficacy of epothilone B loaded with Escherichia coli Nissle 1917 bacterial ghosts on the HeLa cells by mitochondrial pathway of apoptosis.
Zhu W; Hao L; Liu X; Borrás-Hidalgo O; Zhang Y
Drug Dev Ind Pharm; 2018 Aug; 44(8):1328-1335. PubMed ID: 29521115
[TBL] [Abstract][Full Text] [Related]
5. Strategies to release doxorubicin from doxorubicin delivery vehicles.
Li J; Zhang B; Yue C; Wu J; Zhao L; Sun D; Wang R
J Drug Target; 2018 Jan; 26(1):9-26. PubMed ID: 28805085
[TBL] [Abstract][Full Text] [Related]
6. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation.
Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z
Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702
[TBL] [Abstract][Full Text] [Related]
7. Bacterial Ghosts Carrying 5-Fluorouracil: A Novel Biological Carrier for Targeting Colorectal Cancer.
Youssof AME; Alanazi FK; Salem-Bekhit MM; Shakeel F; Haq N
AAPS PharmSciTech; 2019 Jan; 20(2):48. PubMed ID: 30617674
[TBL] [Abstract][Full Text] [Related]
8. Vision of bacterial ghosts as drug carriers mandates accepting the effect of cell membrane on drug loading.
Alanazi FK; Alsuwyeh AA; Haq N; Salem-Bekhit MM; Al-Dhfyan A; Shakeel F
Drug Dev Ind Pharm; 2020 Oct; 46(10):1716-1725. PubMed ID: 32893682
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
Alexander CM; Hamner KL; Maye MM; Dabrowiak JC
Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830
[TBL] [Abstract][Full Text] [Related]
10. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
11. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.
Tinkov S; Coester C; Serba S; Geis NA; Katus HA; Winter G; Bekeredjian R
J Control Release; 2010 Dec; 148(3):368-72. PubMed ID: 20868711
[TBL] [Abstract][Full Text] [Related]
12. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
14. Folate conjugated doxorubicin-loaded membrane vesicles for improved cancer therapy.
Mishra PR; Jain NK
Drug Deliv; 2003; 10(4):277-82. PubMed ID: 14612344
[TBL] [Abstract][Full Text] [Related]
15. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
[TBL] [Abstract][Full Text] [Related]
16. pH-responsive Virus-like Nanoparticles with Enhanced Tumour-targeting Ligands for Cancer Drug Delivery.
Biabanikhankahdani R; Alitheen NBM; Ho KL; Tan WS
Sci Rep; 2016 Nov; 6():37891. PubMed ID: 27883070
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
18. Bacterial ghosts are an efficient delivery system for DNA vaccines.
Ebensen T; Paukner S; Link C; Kudela P; de Domenico C; Lubitz W; Guzmán CA
J Immunol; 2004 Jun; 172(11):6858-65. PubMed ID: 15153504
[TBL] [Abstract][Full Text] [Related]
19. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
[TBL] [Abstract][Full Text] [Related]
20. Bacterial Ghosts as antigen and drug delivery system for ocular surface diseases: Effective internalization of Bacterial Ghosts by human conjunctival epithelial cells.
Kudela P; Koller VJ; Mayr UB; Nepp J; Lubitz W; Barisani-Asenbauer T
J Biotechnol; 2011 May; 153(3-4):167-75. PubMed ID: 21501636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
